Lou Basenese - 25 Aug 2021 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role: Director
Signature: /s/ Louis J. Basenese by Mark Busch, attorney-in-fact
Issuer symbol: NDRA
Transactions as of: 25 Aug 2021
Net transactions value: -$91,600
Form type: 4
Filing time: 27 Aug 2021, 16:15:10 UTC
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NDRA	Common Stock	Sale	$82,350	-45,000	-45%	$1.83	54,068	25 Aug 2021	Direct	F1
transaction	NDRA	Common Stock	Sale	$9,250	-5,000	-9.2%	$1.85	49,068	26 Aug 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.84, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.84, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.